Neurobiology of a Mutation in Glycine Metabolism in Psychotic Disorders

NCT01720316 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Schizo-affective Disorder
Bipolar Disorder

Interventions

DRUG: Glycine
DRUG: placebo

Sponsor

Mclean Hospital

Collaborators

[object Object]